The precise contribution of FcγRIIb in cross-protection against influenza vaccines has remained unclear, although activating FcγR-mediated effector functions have been extensively studied (Bournazos et al., 2020; DiLillo et al., 2014, 2016). This evidence concerns the gene FCGR2A and influenza.